Table 1.

Relationship between the expression level of TGFB1 and clinical characteristics in ES.

Characteristic	Low expression of TGFBI	High expression of TGFBI	p
n	50	51
Metastasis, n (%)			0.686
No	39 (38.6%)	37 (36.6%)
Yes	11 (10.9%)	14 (13.9%)
Tumor region, n (%)			1.000
Distal	18 (28.1%)	18 (28.1%)
Other	2 (3.1%)	1 (1.6%)
Proximal	12 (18.8%)	13 (20.3%)
Proximal and distal	0 (0%)	0 (0%)
Age, n (%)			1.000
<18	39 (38.6%)	39 (38.6%)
≥18	11 (10.9%)	12 (11.9%)
Gender, n (%)			0.372
Female	23 (22.8%)	18 (17.8%)
Male	27 (26.7%)	33 (32.7%)
Race, n (%)
American Indian or Alaska Native	0 (0%)	1 (1.3%)
Asian	3 (3.9%)	4 (5.3%)
Black or African American	5 (6.6%)	5 (6.6%)
Native Hawaiian or other Pacific Islander	0 (0%)	0 (0%)
White	28 (36.8%)	30 (39.5%)
Age, median (IQR)	15.27 (12.35, 17.69)	15.06 (12.63, 17.77)	0.989